Maternal HIV/AIDS status and neurological outcomes in neonates: A population-based study

Maternal and Child Health Journal

Volumn 16, Issue 3, 2012, Pages 641-648

  Salihu, Hamisu M ^a,b   August, Euna M ^a   Aliyu, Muktar ^c   Stanley, Kara M ^d   Weldeselasse, Hanna ^a   Mbah, Alfred K ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d Maine Center for Disease Control   (United States)

Author keywords

HIV AIDS; Neonatal; Pregnancy; Racial disparity; Women

Indexed keywords

ADULT; AIDS RELATED COMPLEX; ARTICLE; DELIVERY; FEMALE; FETUS DISTRESS; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MALE; MOTHER; NEUROLOGIC DISEASE; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; SOCIOECONOMICS; STATISTICAL MODEL; UNITED STATES; VIROLOGY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DELIVERY, OBSTETRIC; FEMALE; FETAL DISTRESS; FLORIDA; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MOTHERS; NERVOUS SYSTEM DISEASES; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84860857768     PISSN: 10927875     EISSN: 15736628     Source Type: Journal    
DOI: 10.1007/s10995-011-0799-4     Document Type: Article

References (40)

1. Center for Disease Control and Prevention. (2008). Estimates of new HIV infections in the United States: Fact sheet. Atlanta, GA: Center for Disease Control and Prevention. Available at: www.cdc. gov/hiv/topics/surveillance/ resources/factsheets/pdf/incidence. pdf.
2. Hall, H. I., Song, R., Rhodes, P., et al. (2008). Estimation of HIV Incidence in the United States. Journal of the American Medical Association, 300(5), 520-529.
3. Kaiser Family Foundation. (2009). Women and HIV/AIDS in the United States: Fact sheet. Menlo Park, CA: Kaiser Family Foundation. Available at: www.kff.org/hivaids/upload/6092-07. pdf.
4. Leroy, V., Ladner, J., Nyiraziraje, M., et al. (1998). Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994: Pregnancy and HIV Study Group. Acquired Immune Deficiency Syndrome, 12(6), 643-650. (Pubitemid 28162104)
5. Mofenson, L. M. (2002). US Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV- 1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Morbidity and Mortality Weekly Report. Recommendations and Report, 51(RR- 18), 1-38.
6. Florida Department of Health. (2008). HIV/AIDS among pediatrics: Fact sheet. Tallahassee, FL: Florida Department of Health. Accessed at: www.doh.state.fl.us/disease-ctrl/aids/updates/facts/2008-Pediatric-Fact-Sheet. pdf.
7. Schulte, J., Dominguez, K., Sukalac, T., et al. (2007). Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: pediatric spectrum of HIV disease, 1989-2004. Pediatrics, 119(4), e900-e906. (Pubitemid 46556654)
8. Lambert, J. S., Watts, D. H., Mofenson, L., et al. (2000). Risk factors for preterm birth, low birthweight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine: Pediatric AIDS Clinical Trials Group 185 team. Acquired Immune Deficiency Syndrome, 14(10), 1389-1399. (Pubitemid 30459512)
9. Suy, A., Martínez, E., Coll, O., et al. (2006). Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. Acquired Immune Deficiency Syndrome, 20, 59-66. (Pubitemid 41818115)
10. Lepage, P., Dabis, F., Hitimana, D. G., et al. (1991). Perinatal transmission of HIV-1: Lack of impact of maternal HIV infection on characteristics of livebirths and on neonatal mortality in Kigali, Rwanda. Acquired Immune Deficiency Syndrome, 5(3), 295-300.
11. Martin, R., Boyer, P., Hammill, H., et al. (1997). Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers: The Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Infection Study Group. Journal of Pediatric, 131(6), 851-856.
12. Alexander, G. R., & Cornely, D. A. (1987). Prenatal care utilization: its measurement and relationship to pregnancy outcome. American Journal of Preventive Medicine, 3, 243-253.
13. Dominguez, K. L., Lindergren, M. L., D'Almada, P. J., et al. (2003). Increasing trend of cesarean deliveries in HIV-infected women in the United States from 1994 to 2000. Journal of Acquired Immune Deficiency Syndromes, 33(2), 232-238. (Pubitemid 36793160)
14. Mofenson, L. M. (2002). Centers for Disease Control and Prevention, US Public Health Service Task Force. US Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Morbidity and Mortality Weekly Report. Recommendations and Report, 51, 1-38.
15. Shapiro-Mendoza, C. K. (2009). Infants born late preterm: Epidemiology, trends, and morbidity risk. NeoReviews, 10(6), 287-294.
16. Signore, C., & Klebanoff, M. (2008). Neonatal morbidity and mortality after elective cesarean delivery. Clinics in Perinatology, 35(2), 361-371. (Pubitemid 351649356)
17. Chase, C., Vibbert, M., Pelton, S. I., et al. (1995). Early neurodevelopmental growth in children with vertically transmitted human immunodeficiency virus infection. Archives of Pediatrics and Adolescent Medicine, 149(8), 850-855.
18. Epstein, L. G., Sharer, L. R., Oleske, J. M., et al. (1986). Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics, 78, 678-687. (Pubitemid 16006401)
19. Belman, A. L. (1990). AIDS and pediatric neurology. Neurologic Clinics, 8, 571-603. (Pubitemid 20286396)
20. Belman, A. L., Ultmann, M. H., Horoupian, D., et al. (1985). Neurological complications in infants and children with acquired immunodeficiency syndrome. Annals of Neurology, 18, 560-566. (Pubitemid 16258091)
21. Epstein, L. G., Sharer, L. R., & Goudsmit, J. (1988). Neurological and neuropathological features of human immunodeficiency virus infection in children. Annals of Neurology, 23(Suppl), S19-S23.
22. Gelbard, H. A., & Epstein, L. G. (1995). HIV-1 encephalopathy in children. Current Opinion in Pediatrics, 7, 655-662.
23. Indacochea, F. J., & Scott, G. B. (1992). HIV-1 infection and the acquired immunodeficiency syndrome in children. Current Problems in Pediatrics, 22(4), 166-204.
24. Melvin, D., Wright, C., & Goddard, S. (1997). Incidence and nature of feeding problems in young children referred to a paediatric HIV service in London: FEAD screening. Child: Care, Health and Development, 23(4), 297-313. (Pubitemid 127516289)
25. Harris, G., & Booth, I. W. (1992). The nature and management of eating problems in pre-school children. In P. J. Cooper & A. Stein (Eds.), Feeding problems and eating disorders in children and adolescents (pp. 61-84). Switzerland: Harwood Academic Publishers.
26. Hirschfeld, S. (1996). Dysregulation of growth and development in HIV-infected children. Journal of Nutrition, 126(Suppl 10), S2641-S2650.
27. Agostoni, C., Zuccotti, G. V., Giovannini, M., et al. (1998). Growth in the first 2 years of uninfected children born to HIV-1 seropositive mothers. Archives of Disease in Childhood, 79, 175-178. (Pubitemid 28384857)
28. Lipman, T. H., Deatrick, J. A., Treston, C. S., et al. (2002). Assessment of growth and immunologic function in HIV-infected and exposed children. The Journal of the Association of Nurses in AIDS Care, 13, 37-45.
29. Gertner, J. M., Kaufman, F. R., Donfield, S. M., et al. (1994). Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys: Hemophilia Growth and Development Study. Journal of Pediatric, 124, 896-902. (Pubitemid 24184014)
30. Pollack, H., Kuchuk, A., Cowan, L., et al. (1996). Neurodevelopment, growth, and viral load in HIV-infected infants. Brain, Behavior, and Immunity, 10, 298-312. (Pubitemid 27007856)
31. Newell, M. L., Borja, M. C., & Peckham, C. (2003). Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics, 111, e52-e60.
32. Isanaka, S., Duggan, C., & Fawzi, W. W. (2009). Patterns of postnatal growth in HIV-infected and HIV-exposed children. Nutrition Review, 67(6), 343-359.
33. Ellis, J., Williams, H., Graves, W., & Lindsay, M. K. (2002). Human immunodeficiency virus infection is a risk factor for adverse perinatal outcome. American Journal of Obstetrics and Gynecology, 186(5), 903-906.
34. Schneider, J. W., & Chasnoff, I. J. (1989). Cocaine abuse during pregnancy: its effect on infant motor development: a clinical perspective. Top Acute Care Rehabilitation, 2, 59-69.
35. Neuspiel, D. R., & Hamel, S. C. (1991). Cocaine and infant behavior. Journal of Developmental and Behavioral Pediatrics, 12, 55-64.
36. Chasnoff, I. J., Griffith, D. R., Freier, C., & Murray, J. (1992). Cocaine/polydrug abuse in pregnancy: 2-year follow-up. Pediatrics, 89, 284-289.
37. Streissguth, A. P., Barr, H. M., Sampson, P. D., Darby, B. L., & Martin, D. C. (1989). IQ at age 4 in relation to maternal alcohol use and smoking during pregnancy. Developmental Psychobiology, 25, 3-11.
38. Fried, P. A., O'Connell, C. M., & Watkinson, B. (1991). 60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment. Journal of Developmental and Behavioral Pediatrics, 13, 383-391.
39. Barret, B., Tardieu, M., Rustin, P., et al. (2003). Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort. Acquired Immune Deficiency Syndrome, 17(12), 1769-1785. (Pubitemid 37000095)
40. Landreau-Mascaro, A., Barret, B., Mayaux, M. J., et al. (2002). Risk of early febrile seizure with perinatal exposure to nucleoside analogues. Lancet, 359(9306), 583-584. (Pubitemid 34178445)